Ferrer, Leti and Oryzon to collaborate in R&D
Catalan Economy
21 Nov 2009
Pharmaceutical companies Ferrer and Leti and biotech firm Oryzon have announced the creation of the Oncochip alliance to further develop cancer research in Catalonia. Madrid-based Ingenasa and Navarra’s CIMA are also to participate in the project.
With a budget of over EUR 20 million, Oncochip will focus on the design of therapies for early diagnosis of ovarian cancer, melanoma and colon cancer. Oryzon specializes in the detection of cancer biomarkers and is already working with Reig Jofré on uterine cancer research.
Ferrer, Leti and Oryzon also plan to create a new partnership next year to develop nanotechnology projects.
Source: Expansión Cataluña 16/11/2009
Related News and Success stories.
-
23 Oct 2024
Catalonia is home to 9,602 foreign companies, a record high and a 68% increase over the past decade
-
17 Oct 2024
A group of 20 Catalan clusters travel to China to explore innovation opportunities and build alliances
-
15 Oct 2024
LCI Education invests €33 million in a new European hub in Barcelona
-
30 Sep 2024
Cluster participation in Catalonia rises 30%, hitting a record of 3,000 companies